|  | |
|  | |
| Clinical data | |
|---|---|
| Trade names | Magnacort, Ulcort | 
| Other names | 11β,17α-Dihydroxy-3,20-dioxopregn-4-en-21-yl N,N-diethylglycinate | 
| Routes of administration | Topical | 
| Pharmacokinetic data | |
| Excretion | Hepatic | 
| Identifiers | |
| 
 | |
| CAS Number | |
| PubChem CID | |
| PubChem SID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.000.877 | 
| Chemical and physical data | |
| Formula | C27H41NO6 | 
| Molar mass | 475.626 g·mol−1 | 
| 3D model (JSmol) | |
| 
 | |
| 
 | |
Hydrocortamate (brand names Magnacort, Ulcortis) is a synthetic glucocorticoid with anti-inflammatory and immunosuppressive properties.[1][2] It is used topically to treat inflammation due to corticosteroid-responsive dermatoses.[3]
References
- ↑ Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 317–. ISBN 978-1-4757-2085-3.
- ↑ Index Nominum 2000: International Drug Directory. Taylor & Francis. 2000. pp. 524–. ISBN 978-3-88763-075-1.
- ↑ DrugBank DB00769
    This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.